Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Study OPL-0301-201 is intended to generate efficacy and safety data of OPL-0301 in participants with post-myocardial infarction (MI) left ventricular dysfunction (LVD)
Epistemonikos ID: b6920a73c181645ca97ee42ad53e47f78bc6a73b
First added on: May 13, 2024